Mylan NV (MYL) reported quarterly earnings results on Tuesday, Aug-9-2016. The company said it had a profit of $1.16 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.03. Analysts had a consensus of $1.13. The company posted revenue of $2560.70 million in the period, compared to analysts expectations of $2572.65 million. The company’s revenue was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 EPS.
Mylan NV opened for trading at $48.42 and hit $49.32 on the upside on Monday, eventually ending the session at $48.53, with a gain of 0.14% or 0.07 points. The heightened volatility saw the trading volume jump to 67,08,711 shares. Company has a market cap of $24,670 M.
In a different news, on Jun 6, 2016, Joseph C Md Maroon (director) purchased 1,670 shares at $44.95 per share price. According to the SEC, on May 25, 2016, Robert J Cindrich (director) purchased 1,190 shares at $42.47 per share price. On May 16, 2016, Melina E Higgins (director) purchased 19,900 shares at $38.68 per share price, according to the Form-4 filing with the securities and exchange commission.
Mylan N.V. formerly Mylan Inc. is a global pharmaceutical company which develops licenses manufactures markets and distributes generic branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty. The Companys generic pharmaceutical business is conducted primarily in the United States and Canada (collectively North America); Europe the Middle East and Africa (collectively EMEA); and India Australia Japan and New Zealand (collectively Asia Pacific). Its specialty pharmaceutical business is conducted by Mylan Specialty L.P. (Mylan Specialty). The Companys API business is conducted through Mylan Laboratories Limited (Mylan India) which is included within the Asia Pacific region in its Generics Segment. Mylan provides products to customers in approximately 140 countries and territories.